abstract |
Disclosed is a pharmaceutical composition containing a polypeptide having a PH domain of a PHLDA family protein. Also disclosed is a pharmaceutical preparation for treating tumors, which comprises the pharmaceutical composition. The pharmaceutical composition contains a polypeptide having a PH domain of a PHLDA family protein or an expression vector having, inserted therein, DNA encoding the polypeptide. The pharmaceutical preparation comprising the pharmaceutical composition can be used for the treatment of tumors. |